Klotho Neurosciences Inc Share Price & Technical Analysis
KLTO
Healthcare / Biotechnology
—
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its…
Price chart
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$56.66M
P/E ratio
—
52W high
$3.91
52W low
$0.11
Beta
2.23
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹35,920
Abbott Laboratories Cede…
₹33,540
Eli Lilly And Company Ce…
₹30,700
Unitedhealth Group Inc C…
₹18,590
₹7,059
Frequently asked questions
- What is Klotho Neurosciences Inc share price today?
- Live KLTO price data is available on StockPro during market hours with charts, technicals, and AI analysis.
- What technical signals does KLTO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for KLTO. Download the app for real-time alerts.
- How can I analyze Klotho Neurosciences Inc stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.